NDC codes

FDA NDC Directory
Product NDC (as listed)64380-213Labeler and product segments. Claims need a package NDC.
Product NDC at billing width64380-0213Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
64380-213-0164380021301100 TABLET in 1 BOTTLE (64380-213-01)Marketed from Mar 14, 2022
64380-213-0264380021302500 TABLET in 1 BOTTLE (64380-213-02)Marketed from Feb 28, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Methimazole
Generic name (nonproprietary)
methimazole
Active ingredients
Methimazole — 10 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 040350
Marketing start
Listing expires
Other FDA classes
Thyroid Hormone Synthesis Inhibitors (Mechanism)
Identifiers
Product ID 64380-213_e355c721-78d1-4a61-96db-77df6c5b41edSPL ID e355c721-78d1-4a61-96db-77df6c5b41edSPL set ID 0f5fb0a4-feb9-4b86-9a93-b2c84cfc082fRxCUI 197941, 197942UNII 554Z48XN5EUPC 0364380212010, 0364380213017
Pharmacologic class
Thyroid Hormone Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464380021301 followed by a unit qualifier and the quantity

Package 64380-0213-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Methimazole tablets are indicated: In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040350

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040350
ProductStrengthForm · routeLabelerProduct NDC
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack71335-2349
MethimazoleMethimazole 5 mg/1TabletOralStrides Pharma Science Limited64380-212
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack71335-2881
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack72162-1802
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack72162-1803
MethimazoleMethimazole 5 mg/1TabletOralREMEDYREPACK INC.70518-4747
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack71335-2906
MethimazoleMethimazole 5 mg/1TabletOralAmerican Health Packaging60687-669
MethimazoleMethimazole 10 mg/1TabletOralAmerican Health Packaging60687-680
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack63629-9251
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack63629-9249
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack63629-9250
MethimazoleMethimazole 10 mg/1TabletOralBryant Ranch Prepack71335-3027
MethimazoleMethimazole 5 mg/1TabletOralBryant Ranch Prepack71335-3026

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in